GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
5.5k
c/tirzepatide·posted 8 months ago by u/kian_ekstrom

[Results] 67 weeks, 10kg, and dual agonist was the hard part

Results Clean Column ×8 Sourced ×1 Slow Clap ×3

67 weeks, 10kg, and dual agonist was the hard part, and the part I actually want to talk about is at the bottom.

To save the first four comments: 67 weeks and 10kg.

Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run. Dropped back to 10 and everything settled.

28kg over 59 weeks, never went past 10mg, and nausea stayed mild the whole way. Posting because the loud threads are all 15mg.

That is everything I have. The rest is opinion and I have tried to keep it out.

6,443 up / 920 down88% upvoted21 commentsid 1sn6wm1 Dec 2025

21 comments

15 in this archive, depth 4

best — the order this archive was captured in

u/rania_marchand745 points·7 months ago

Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.

replysharereportpermalink
u/titration_marshalmod · c/semaglutide604 points·7 months ago

Reminder that nobody in this thread is your clinician and the sidebar says so for a reason.

replysharereportpermalink
u/elin_ferrari0 points·7 months ago

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

replysharereportpermalink
u/piotr_nascimento-19 points·8 months ago·edited

Which week did the appetite change actually land for you?

replysharereportpermalink
u/kaia_cabrera361 points·7 months ago

the trials titrated on a calendar, real people titrate on symptoms

replysharereportpermalink
u/kian_ekstromOP166 points·7 months ago

Does reflux follow the day after the shot, or is it spread across the week?

replysharereportpermalink
u/emil_barros56 points·7 months ago

a lot of people plateau nicely at 10mg and never need 15

replysharereportpermalink
u/kian_ekstromOP33 points·7 months ago

hold the dose that works, the ladder is not a leaderboard

replysharereportpermalink
u/marit_sandvik167 points·7 months ago

What is the waist doing? That is usually the number still moving during a scale stall.

replysharereportpermalink
u/kaia_wojcik90 points·7 months ago

The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 50 is not a fair reading.

replysharereportpermalink
u/forest_plot_fionastats115 points·7 months ago

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

replysharereportpermalink
u/incretin_ivypharmacology31 points·7 months ago

Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.

replysharereportpermalink
u/ignacio_vanhecke13 points·7 months ago

Right. And the sema-to-tirz "conversion" people post is invented. There is no published equivalence.

replysharereportpermalink
u/coring_the_stopper52 points·7 months ago

The four-week interval in the label is a minimum.

Not sure about this bit. The GIP arm being real does not tell you that it is what caused your particular week.

replysharereportpermalink
u/spain_receta22 points·7 months ago

dual agonist, so the GIP arm is doing something the sema threads will not tell you about

replysharereportpermalink
About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.